Family Medicine · St Petersburg, FL
NPI
1235121724
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
530 Tyrone Blvd N
St Petersburg, FL, 33710
Phone (727) 823-3022
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
2,022 services
Medicare patients, 2024
262
Average age 75
Drug cost, 2024
$1.6M
21,799 prescriptions
Company payments, 2025
$209
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew G Smith was code 99214 (office e&m - established), 724 times for 231 patients. In total Matthew G Smith billed 2,022 services in 25 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 724 | 231 | $87.10 | $63K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 502 | 209 | $12.52 | $6,285 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 136 | 136 | $125.39 | $17K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 132 | 20 | $0.75 | $98.42 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 132 | 132 | $17.92 | $2,366 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 130 | 130 | $19.60 | $2,548 |
| 96372 Injection Administration | Office | 56 | 30 | $10.18 | $570 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 38 | 14 | $0.87 | $33.16 |
| 99213 Office E&M - Established | Office | 27 | 22 | $53.40 | $1,442 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 23 | 20 | $112.49 | $2,587 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 17 | 16 | $38.68 | $658 |
| 99204 Office E&M - New | Office | 15 | 15 | $94.85 | $1,423 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 14 | 13 | $117.60 | $1,646 |
| 93000 Electrocardiogram | Office | 12 | 12 | $9.24 | $111 |
By year: 2022 $108K for 1,699 services; 2023 $100K for 1,623 services; 2024 $102K for 2,022 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew G Smith prescribed most often to Medicare patients was Atorvastatin Calcium, with 897 prescriptions and refills. In total Matthew G Smith wrote 21,799 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 897 | 2,412 | 251 | $5,786 |
| Levothyroxine Sodium Generic | 831 | 2,288 | 227 | $11K |
| Rosuvastatin Calcium Generic | 812 | 2,299 | 245 | $6,077 |
| Amlodipine Besylate Generic | 725 | 1,992 | 210 | $2,210 |
| Lisinopril Generic | 711 | 2,032 | 209 | $2,611 |
| Metformin Hcl Generic | 668 | 1,896 | 209 | $2,166 |
| Alprazolam Generic | 645 | 707 | 127 | $3,301 |
| Omeprazole Generic | 599 | 1,613 | 174 | $5,048 |
| Losartan Potassium Generic | 576 | 1,574 | 161 | $2,833 |
| Montelukast Sodium Generic | 425 | 1,119 | 122 | $3,109 |
| Tramadol Hcl Generic | 416 | 422 | 94 | $6,417 |
| Gabapentin Generic | 379 | 717 | 113 | $8,866 |
| Simvastatin Generic | 369 | 1,028 | 106 | $1,727 |
| Temazepam Generic | 347 | 450 | 69 | $2,739 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 345 | 561 | 112 | $11K |
Brand drugs: 2,219 claims; generic drugs: 19,469 claims; opioid claims: 659.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew G Smith $209 ($209 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $126.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.